Globeflex Capital L P Vanda Pharmaceuticals Inc. Transaction History

Globeflex Capital L P

$1.03 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$4.28 - $6.57 $7,858 - $12,062	-1,836 Reduced 1.87%	96,331 $416,000
Q2 2023 Aug 14, 2023	SELL	$5.9 - $6.95 $15,788 - $18,598	-2,676 Reduced 2.65%	98,167 $646,000
Q2 2022 Aug 15, 2022	BUY	$9.31 - $11.84 $21,999 - $27,977	2,363 Added 2.4%	100,843 $1.1 Million
Q1 2022 May 13, 2022	SELL	$10.84 - $16.55 $299,140 - $456,713	-27,596 Reduced 21.89%	98,480 $1.11 Million
Q4 2021 Feb 10, 2022	SELL	$15.69 - $21.14 $1.1 Million - $1.48 Million	-69,950 Reduced 35.68%	126,076 $1.98 Million
Q3 2021 Nov 12, 2021	SELL	$15.35 - $21.27 $42,765 - $59,258	-2,786 Reduced 1.4%	196,026 $3.36 Million
Q2 2021 Aug 12, 2021	BUY	$15.71 - $21.51 $300,422 - $411,335	19,123 Added 10.64%	198,812 $4.28 Million
Q1 2021 May 14, 2021	BUY	$13.42 - $20.28 $176,754 - $267,107	13,171 Added 7.91%	179,689 $2.7 Million
Q4 2020 Feb 11, 2021	BUY	$9.77 - $13.81 $83,181 - $117,578	8,514 Added 5.39%	166,518 $2.19 Million
Q3 2020 Nov 13, 2020	BUY	$9.32 - $12.02 $22,768 - $29,364	2,443 Added 1.57%	158,004 $1.53 Million
Q2 2020 Aug 12, 2020	BUY	$9.66 - $12.02 $97,904 - $121,822	10,135 Added 6.97%	155,561 $1.78 Million
Q4 2019 Feb 07, 2020	BUY	$12.38 - $17.47 $1.2 Million - $1.7 Million	97,219 Added 201.67%	145,426 $2.39 Million
Q3 2019 Nov 13, 2019	BUY	$12.27 - $15.79 $341,768 - $439,814	27,854 Added 136.85%	48,207 $640,000
Q2 2019 Aug 12, 2019	SELL	$13.37 - $18.85 $467,682 - $659,373	-34,980 Reduced 63.22%	20,353 $287,000
Q1 2019 May 10, 2019	SELL	$17.59 - $31.05 $227,086 - $400,855	-12,910 Reduced 18.92%	55,333 $1.02 Million
Q4 2018 Feb 14, 2019	SELL	$18.97 - $31.47 $295,932 - $490,932	-15,600 Reduced 18.61%	68,243 $1.78 Million
Q3 2018 Nov 09, 2018	BUY	$18.25 - $23.0 $363,175 - $457,700	19,900 Added 31.12%	83,843 $1.92 Million
Q2 2018 Aug 10, 2018	BUY	$13.95 - $19.15 $892,004 - $1.22 Million	63,943 New	63,943 $1.22 Million

Others Institutions Holding VNDA

# of Institutions

161

Shares Held

45.2M

Call Options Held

165K

Put Options Held

33.6K

Black Rock Inc. New York, NY

8.14M
Shares

$35.5 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.01M
Shares

$17.5 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

3.63M
Shares

$15.8 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

2.35M
Shares

$10.3 Million
0.94% of portfolio
Dimensional Fund Advisors LP Austin, TX

2.26M
Shares

$9.86 Million
0.0% of portfolio

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $247M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

News

Stay updated on Globeflex Capital L P with notifications on news.

Account